Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating DS-1971a for diabetic peripheral neuropathic pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Neuropathic Pain

Drugs mentioned

• DS-1971A (DS-1971A)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Neuropathic Pain, Diabetes | Phase 2 | Status: WITHDRAWN